Atrial Fibrillation

This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower  ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion

watchman LAA occluder, LAAO registry
Feature | Left Atrial Appendage (LAA) Occluders

November 7, 2016 – Results from the U.S. real-world, post-FDA approval experience of the Watchman device found high ...

Home November 07, 2016
News | EP Mapping and Imaging Systems

October 27, 2016 — Acutus Medical announced the completion of the first patient procedure in the “Utilizing Novel Dipole ...

Home October 27, 2016
News | Atrial Fibrillation

October 25, 2016 — A recent study from University of Alabama at Birmingham (UAB) researchers published in PLOS ONE compa ...

Home October 25, 2016
News | Left Atrial Appendage (LAA) Occluders

October 20, 2016 — SentreHeart Inc. announced in late September the closing of a $35 million Series D round of financing ...

Home October 20, 2016
News | Ablation Systems

October 17, 2016 — Medtronic plc last week unveiled new health economic analysis data from the FIRE AND ICE trial that ...

Home October 17, 2016
News | Left Atrial Appendage (LAA) Occluders

October 13, 2016 — SentreHeart Inc. announced this week it has treated the first patients using the Eclipse Surgical ...

Home October 13, 2016
CardioKinetix, Parachute device, Heart Failure device therapy
Feature | Heart Failure | Abha Mishra

New cardiovascular device therapies for atrial fibrillation (AF) and heart failure (HF) are rapidly evolving with the ...

Home September 29, 2016
News | EP Lab

September 27, 2016 — In August, the European Heart Rhythm Association (EHRA) and EP Europace journal announced the ...

Home September 27, 2016
News | Antiplatelet and Anticoagulation Therapies

September 1, 2016 — First outcome results from the GLORIA-AF Registry show that treatment with Pradaxa (dabigatran ...

Home September 01, 2016
News | Cardiac Resynchronization Therapy Devices (CRT)

August 30, 2016 — Medtronic plc announced results from the Cardiac Resynchronization Therapy Efficacy Enhancement (CRTee ...

Home August 30, 2016
Cybersecurity concerns were raised over the St. Jude Medical (SJM) Merlin@home EP device home monitoring system
Feature | EP Lab | Dave Fornell

August 29, 2016 — Investment research firm Muddy Waters Capital released a report Aug. 25 saying it believes St. Jude ...

Home August 29, 2016
News | Antiplatelet and Anticoagulation Therapies

August 16, 2016 — Warfarin prescribed to prevent strokes in atrial fibrillation may not adequately control blood ...

Home August 16, 2016
Technology | Ablation Systems

August 15, 2016 — The U.S. Food and Drug Administration has granted market approval for the Biosense Webster Thermocool ...

Home August 15, 2016
Technology | Implantable Cardioverter Defibrillator (ICD)

August 9, 2016 — The U.S. Food and Drug Administration (FDA) granted market approval for the Emblem MRI Subcutaneous ...

Home August 09, 2016
Watchman, left atrial appendage closure, LAA occluder
Feature | Left Atrial Appendage (LAA) Occluders | Dave Fornell

Patients with atrial fibrillation (AF or Afib) are high risk for stroke due to the formation of thrombus emboli in the ...

Home August 01, 2016
Subscribe Now